Ciraci P, Germani MM, Pietrantonio F, Manca P, et al. Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO. Ann Oncol 2025 Oct 18:S0923-7534(25)04934-8. doi: 10.1016/j.annonc.2025.
PMID: 41115464